These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6337093)

  • 1. Properties of synthetically produced Escherichia coli heat-stable enterotoxin.
    Klipstein FA; Engert RF; Houghten RA
    Infect Immun; 1983 Jan; 39(1):117-21. PubMed ID: 6337093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A completely synthetic toxoid vaccine containing Escherichia coli heat-stable toxin and antigenic determinants of the heat-labile toxin B subunit.
    Houghten RA; Engert RF; Ostresh JM; Hoffman SR; Klipstein FA
    Infect Immun; 1985 Jun; 48(3):735-40. PubMed ID: 2581899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine for enterotoxigenic Escherichia coli based on synthetic heat-stable toxin crossed-linked to the B subunit of heat-labile toxin.
    Klipstein FA; Engert RF; Clements JD; Houghten RA
    J Infect Dis; 1983 Feb; 147(2):318-26. PubMed ID: 6338132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in cross-protection in rats immunized with the B subunits of cholera toxin and Escherichia coli heat-labile toxin.
    Klipstein FA; Engert RF; Clements JD; Houghten RA
    Infect Immun; 1984 Mar; 43(3):811-6. PubMed ID: 6365784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection in rabbits immunized with a vaccine of Escherichia coli heat-stable toxin cross-linked to the heat-labile toxin B subunit.
    Klipstein FA; Engert RF; Houghten RA
    Infect Immun; 1983 Jun; 40(3):888-93. PubMed ID: 6682834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of cross-linked toxoid vaccines made with hyperantigenic forms of synthetic Escherichia coli heat-stable toxin.
    Klipstein FA; Engert RF; Houghten RA
    Infect Immun; 1984 May; 44(2):268-73. PubMed ID: 6425218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of active immunization with purified Escherichia coli heat-labile enterotoxin in rats.
    Klipstein FA; Engert RF
    Infect Immun; 1979 Mar; 23(3):592-9. PubMed ID: 378831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against human and porcine enterotoxigenic strains of Escherichia coli in rats immunized with a cross-linked toxoid vaccine.
    Klipstein FA; Engert RF; Clements JD; Houghten RA
    Infect Immun; 1983 Jun; 40(3):924-9. PubMed ID: 6343245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization of rats with heat-labile enterotoxin provides uniform protection against heterologous serotypes of enterotoxigenic Escherichia coli.
    Klipstein FA; Engert RF; Clements JD
    Infect Immun; 1981 Jun; 32(3):1100-4. PubMed ID: 7019087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a vaccine of cross-linked heat-stable and heat-labile enterotoxins that protects against Escherichia coli producing either enterotoxin.
    Klipstein FA; Engert RF; Clements JD
    Infect Immun; 1982 Aug; 37(2):550-7. PubMed ID: 6749682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological cross-reactivity of heat-labile enterotoxins produced by enterotoxigenic and enteropathogenic strains of Escherichia coli.
    Klipstein FA; Engert RF; Short HB
    Immunology; 1980 Sep; 41(1):115-21. PubMed ID: 7000692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological properties of purified Klebsiella pneumoniae heat-stable enterotoxin.
    Klipstein FA; Engert RF; Houghten RA
    Infect Immun; 1983 Nov; 42(2):838-41. PubMed ID: 6358035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal antitoxin response in volunteers to immunization with a synthetic peptide of Escherichia coli heat-stable enterotoxin.
    Klipstein FA; Engert RF; Houghten RA
    Infect Immun; 1985 Oct; 50(1):328-32. PubMed ID: 3899936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of immunization of rats with holotoxin or B subunit of Escherichia coli heat-labile enterotoxin.
    Klipstein FA; Engert RF
    Infect Immun; 1981 Jan; 31(1):144-50. PubMed ID: 7011990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroral immunization of rats with Escherichia coli heat-labile enterotoxin delivered by microspheres.
    Klipstein FA; Engert RF; Sherman WT
    Infect Immun; 1983 Feb; 39(2):1000-3. PubMed ID: 6339378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of neutralizing monoclonal antibodies to Escherichia coli heat-stable enterotoxin.
    Brandwein H; Deutsch A; Thompson M; Giannella R
    Infect Immun; 1985 Jan; 47(1):242-6. PubMed ID: 3880723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arousal of mucosal secretory immunoglobulin A antitoxin in rats immunized with Escherichia coli heat-labile enterotoxin.
    Klipstein FA; Engert RF; Clements JD
    Infect Immun; 1982 Sep; 37(3):1086-92. PubMed ID: 7129629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological relationship of the B subunits of Campylobacter jejuni and Escherichia coli heat-labile enterotoxins.
    Klipstein FA; Engert RF
    Infect Immun; 1985 Jun; 48(3):629-33. PubMed ID: 3922890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection in rats immunized with Escherichia coli heat-stable enterotoxin.
    Klipstein FA; Engert RF; Clements JD
    Infect Immun; 1981 Nov; 34(2):637-9. PubMed ID: 7030964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological interrelationships between cholera toxin and the heat-labile and heat-stable enterotoxins of coliform bacteria.
    Klipstein FA; Engert RF
    Infect Immun; 1977 Oct; 18(1):110-7. PubMed ID: 332637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.